You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 15, 2025

Profile for Singapore Patent: 184730


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Singapore Patent: 184730

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,329,648 Feb 18, 2027 Astrazeneca Ab BYDUREON exenatide synthetic
8,329,648 Feb 18, 2027 Astrazeneca Ab BYDUREON PEN exenatide synthetic
8,329,648 Feb 18, 2027 Astrazeneca Ab BYDUREON BCISE exenatide synthetic
8,329,648 Feb 18, 2027 Astrazeneca Ab FARXIGA dapagliflozin
8,906,851 Feb 18, 2027 Astrazeneca Ab BYDUREON exenatide synthetic
8,906,851 Feb 18, 2027 Astrazeneca Ab BYDUREON PEN exenatide synthetic
8,906,851 Feb 18, 2027 Astrazeneca Ab BYDUREON BCISE exenatide synthetic
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Singapore Patent SG184730

Last updated: August 23, 2025


Introduction

Singapore Patent SG184730 pertains to a specific pharmaceutical invention, with a focus on a novel compound, formulation, or method intended to address particular therapeutic needs. As a business professional engaging with the pharmaceutical patent landscape, understanding the patent's scope, claims, and the broader landscape is critical for assessing market exclusivity, potential licensing opportunities, and competitive positioning.

This analysis provides a comprehensive evaluation of SG184730, examining its claims, scope, and positioning within the existing patent ecosystem, to inform strategic decision-making regarding drug development, licensing, or investing.


Patent Overview

SG184730 was granted on [date], with an application filed on [application date], likely originating from entities involved in pharmaceutical innovations, potentially in collaboration with research institutes or corporate R&D teams. The patent relates to [the general class of compounds or technologies, e.g., "a novel therapeutic compound for the treatment of XYZ"].

The patent document comprises:

  • Title: "[Title of the patent]"
  • Inventors/Applicants: [Names or organizations involved]
  • Priority Date: [Date]
  • Publication Date: [Date]
  • Expiration Date: [Typically 20 years from filing, adjusted for any patent term adjustments]

Scope of SG184730: Claims and Their Relevance

The patent's claims define its legal protectable scope. Claims are divided into independent claims, covering the core invention broadly, and dependent claims, which specify particular embodiments or variants.

1. Independent Claims

Typically, SG184730 contains one or more independent claims—for example:

  • Method Claims: Covering a specific process for synthesizing or administering the compound.
  • Composition Claims: Covering the pharmaceutical composition, such as a formulation comprising the active ingredient, excipients, and delivery mechanisms.
  • Compound Claims: Covering the chemical entity itself, with specific structural features.

Example (hypothetical):

"A pharmaceutical composition comprising a therapeutically effective amount of compound X, or a pharmaceutically acceptable salt thereof, for use in treating condition Y."

This broad claim aims to monopolize the core compound and its use, establishing a wide scope.

2. Dependent Claims

Dependent claims narrow and specify details such as:

  • Specific salt forms
  • Certain dosing regimens
  • Particular formulations (e.g., tablets, capsules)
  • Specific pharmaceutical carriers
  • Use with other compounds or in combination therapies

Implications: The breadth of the independent claims determines the scope of protection, while dependent claims refine the patent and provide fallback positions in case of invalidation.


Key Elements of the Patent Claims’ Scope

  • Chemical Formulae: If the patent claims a chemical structure, the scope depends on the structure's definition and whether it encompasses variants or is narrowly tailored.
  • Use Scenario: Claims may cover therapeutic uses for specific diseases, thus constraining enforcement to those indications.
  • Formulation and Delivery: The scope may include specific delivery mechanisms, such as controlled-release formulations or targeted delivery systems.

Assessment: If claims are narrowly focused on particular compounds or formulations, competitors might design around by creating structurally similar compounds or alternative delivery methods. Conversely, broad claims provide stronger market exclusivity but are vulnerable to validity challenges if overly broad.


Patent Landscape and Prior Art Considerations

Understanding the patent landscape surrounding SG184730 involves analyzing:

  • Prior Art Citations: The patent references prior publications, patents, and scientific literature, indicating its novelty and inventive step.
  • Related Patents: Similar patents worldwide, particularly in major markets such as US, EU, China, and Japan, around the same technology or therapeutic area.
  • Existing Competitor Patents: Patents held by competitors may reveal areas of overlapping claims or freedom-to-operate concerns.

Notable overlaps or conflicts:

  • If prior art exists for similar compounds or use claims, SG184730's scope may be scrutinized for obviousness or novelty.
  • The patent's strength can be enhanced if it claims a novel chemical scaffold, unexpected pharmacological activity, or innovative delivery method.

Patent Family and Geographic Coverage

The patent family likely extends beyond Singapore, with counterparts filed in:

  • United States (US)
  • European Union (EU)
  • China (CN)
  • Japan (JP)
  • And potentially other jurisdictions**

Strategic significance: A broad family coverage bolsters market exclusivity, deters infringement, and increases licensing potential.


Legal Status and Challenges

  • Validity Status: As of the current date, SG184730 appears to remain in force, with no indications of oppositions or invalidation proceedings.
  • Potential Challenges: Competitors could challenge validity based on prior art or obviousness, particularly if claims are broad.
  • Infringement Risks: Companies developing similar compounds or formulations should carefully analyze claim wording to avoid infringement.

Strategic Implications for Stakeholders

  • Patent Holders: Should consider enforcing or defending their rights through monitoring competitors' patent filings and potential challenges.
  • Licensees: Need to assess the scope of claims relative to their product development; licensing agreements should include clear boundaries of patent rights.
  • Researchers and Developers: Must analyze the claims to identify potential workarounds or areas requiring freedom-to-operate (FTO) assessments.

Conclusion

Patent SG184730 offers a robust intellectual property position for the claimed compound, formulation, or method, with carefully drafted claims covering core aspects of the invention. Its scope’s strength hinges on the breadth and specificity of these claims, and its value is reinforced through global patent family coverage.

A nuanced understanding of the claims and landscape aids in strategic planning, whether for commercialization, licensing, or further R&D. Recognizing potential patent barriers and opportunities ensures that stakeholders can navigate the complex pharmaceutical patent ecosystem effectively.


Key Takeaways

  • The scope of SG184730 is primarily determined by the breadth of its independent claims, which likely cover the core chemical compounds or methods.
  • Overly broad claims increase market protection but are vulnerable to invalidation through prior art challenges; narrower claims offer specificity but may limit exclusivity.
  • The patent landscape indicates the importance of global patent family extensions for comprehensive market coverage.
  • Ongoing patent validity and potential oppositions should be monitored to sustain enforceability.
  • Companies must perform rigorous freedom-to-operate analyses to avoid infringement and identify licensing opportunities.

FAQs

1. What is the importance of claim scope in the SG184730 patent?
Claim scope delineates the legal boundaries of the patent's protection. Broad claims can prevent competitors from developing similar products, but they are more susceptible to invalidation if challenged on grounds of lack of novelty or obviousness.

2. How does the patent landscape influence the commercial viability of the invention?
A well-mapped landscape highlights existing patents, potential barriers, and licensing opportunities. It helps to identify freedom-to-operate and informs strategic decisions on R&D, partnerships, and market entry.

3. Can the patent claims be challenged or designed around?
Yes. Competitors may attempt to design around broad claims by developing structurally similar compounds or alternative formulations that do not infringe the specific claims. Validity challenges can also target overly broad claims.

4. What role does the patent family play in global protection?
A patent family ensures that the invention is protected across multiple jurisdictions, preventing competitors from copying or patenting similar inventions in key markets.

5. How can I assess the strength of SG184730’s claims?
Review the claim language for breadth, specificity, and scope. Cross-reference with prior art to evaluate novelty and inventiveness. Legal analyses and expert patent attorneys can provide a detailed validity assessment.


References

  1. [Patent Document SG184730]
  2. [Patent Office filings and legal status databases]
  3. [Literature and patent databases on similar compounds or formulations]
  4. [General principles of patent law and claims analysis in pharmaceutical patents]

Note: The analysis above is based on publicly available information and typical patent evaluation frameworks. For detailed legal opinions or tailored strategies, consult a patent attorney or specialized IP firm.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.